Notify me when Sporos Bioventures LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CARA | Tvardi Therapeutics, Inc. | Common Stock, par value $0.001 per share | 8.95% | $4,456,224 | 837,636 | Sporos Bioventures LLC | 15 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|